Activation of Alternative Lengthening of Telomeres (ALT) in Primary Pancreatic Neuroendocrine Tumors Serves as Both a Prognostic Biomarker and Potential Therapeutic Target

被引：0
|
作者：
Rizzo, Anthony [1 ]
Brosnan-Cashman, Jacqueline [1 ]
Graham, Mindy [1 ]
Hruban, Ralph [1 ]
Heaphy, Christopher [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
PANCREAS | 2018年 / 47卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 46 条
  • [31] B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors
    Rasic, Petar
    Jovanovic-Tucovic, Maja
    Jeremic, Marija
    Djuricic, Slavisa M.
    Vasiljevic, Zorica V.
    Milickovic, Maja
    Savic, Djordje
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (08) : 799 - 821
  • [32] Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
    Hackeng, Wenzel M.
    Brosens, Lodewijk A. A.
    Kim, Joo Young
    O'Sullivan, Roderick
    Sung, You-Na
    Liu, Ta-Chiang
    Cao, Dengfeng
    Heayn, Michelle
    Brosnan-Cashman, Jacqueline
    An, Soyeon
    Morsink, Folkert H. M.
    Heidsma, Charlotte M.
    Valk, Gerlof D.
    Vriens, Menno R.
    van Dijkum, Els Nieveen
    Offerhaus, G. Johan A.
    Dreijerink, Koen M. A.
    Zeh, Herbert
    Zureikat, Amer H.
    Hogg, Melissa
    Lee, Kenneth
    Geller, David
    Marsh, J. Wallis
    Paniccia, Alessandro
    Ongchin, Melanie
    Pingpank, James F.
    Bahary, Nathan
    Aijazi, Muaz
    Brand, Randall
    Chennat, Jennifer
    Das, Rohit
    Fasanella, Kenneth E.
    Khalid, Asif
    McGrath, Kevin
    Sarkaria, Savreet
    Singh, Harkirat
    Slivka, Adam
    Nalesnik, Michael
    Han, Xiaoli
    Nikiforova, Marina N.
    Lawlor, Rita Teresa
    Mafficini, Andrea
    Rusev, Boris
    Corbo, Vincenzo
    Luchini, Claudio
    Bersani, Samantha
    Pea, Antonio
    Cingarlini, Sara
    Landoni, Luca
    Salvia, Roberto
    GUT, 2022, 71 (05) : 961 - 973
  • [33] Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors
    Mastrosimini, Maria Gaia
    Manfrin, Erminia
    Remo, Andrea
    De Bellis, Mario
    Parisi, Alice
    Pedron, Serena
    Luchini, Claudio
    Brunelli, Matteo
    Ammendola, Serena
    Bernardoni, Laura
    Bellocchi, Maria Cristina Conti
    Gabbrielli, Armando
    Facciorusso, Antonio
    Pea, Antonio
    Landoni, Luca
    Scarpa, Aldo
    Crino, Stefano Francesco
    PANCREATOLOGY, 2023, 23 (04) : 429 - 436
  • [34] Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors
    Mahalakshmi, B.
    Baskaran, Rathinasamy
    Shanmugavadivu, M.
    Nguyen, Ngoc Tuan
    Velmurugan, Bharath Kumar
    CELLULAR ONCOLOGY, 2020, 43 (03) : 367 - 376
  • [35] Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors
    B. Mahalakshmi
    Rathinasamy Baskaran
    M. Shanmugavadivu
    Ngoc Tuan Nguyen
    Bharath Kumar Velmurugan
    Cellular Oncology, 2020, 43 : 367 - 376
  • [36] Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
    de Wilde, Roeland F.
    Heaphy, Christopher M.
    Maitra, Anirban
    Meeker, Alan K.
    Edil, Barish H.
    Wolfgang, Christopher L.
    Ellison, Trevor A.
    Schulick, Richard D.
    Molenaar, I. Quintus
    Valk, Gerlof D.
    Vriens, Menno R.
    Rinkes, Inne H. M. Borel
    Offerhaus, G. Johan A.
    Hruban, Ralph H.
    Matsukuma, Karen E.
    MODERN PATHOLOGY, 2012, 25 (07) : 1033 - 1039
  • [37] LAP2α orchestrates alternative lengthening of telomeres suppression through telomeric heterochromatin regulation with HDAC1: unveiling a potential therapeutic target
    Wang, Bing
    Kou, Haomeng
    Wang, Yuwen
    Zhang, Qi
    Jiang, Duo
    Wang, Juan
    Zhao, Ziqin
    Zhou, Yao
    Zhang, Miaomiao
    Sui, Lei
    Zhao, Mingfeng
    Liu, Yancheng
    Liu, Yang
    Shi, Lei
    Wang, Feng
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [38] SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumours
    Song, Yu-Li
    Weng, Jun-Hua
    Zhao, Da-Chun
    Zhang, Jia-Lei
    Chen, Yuan-Jia
    Xu, Bao-Hong
    ENDOCRINE, 2024, 85 (01) : 407 - 416
  • [39] Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing
    Zheng, Kailian
    Liu, Tao
    Zhao, Jiangman
    Meng, Peng
    Bian, Yun
    Ni, Chenming
    Wang, Huan
    Pan, Yaqi
    Wu, Shouxin
    Jiang, Hui
    Jin, Gang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (05)
  • [40] Evaluating Genetic Alterations in Metastatic Pancreatic Neuroendocrine Tumors with Potential Therapeutic and Prognostic Applications: A Comparative In Silico Study with Metastatic Neuroendocrine Tumors Originating from the Small Intestine and Rectum
    Mousavi, S.
    Baboli, K. Mirzaei
    Arabi, M.
    Bereimipour, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S100 - S101
12345